造影剂诱发的肾病：需要对危险因素进行进一步研究。 - Suppr | 超能文献

Contrast-Induced Nephropathy: Further Investigations About Risk Factors Are Required.

作者信息

Sun Guoli, Chen Ji-Yan, Liu Yong

机构信息

1 Guangdong General Hospital, School of Medicine, South China University of Technology, Guangzhou, China.

出版信息

Angiology. 2019 Sep;70(8):784-785. doi: 10.1177/0003319719857376. Epub 2019 Jun 25.

DOI:10.1177/0003319719857376

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Contrast-Induced Nephropathy: Further Investigations About Risk Factors Are Required.造影剂诱发的肾病：需要对危险因素进行进一步研究。

Angiology. 2019 Sep;70(8):784-785. doi: 10.1177/0003319719857376. Epub 2019 Jun 25.

2

Long-Term Mortality and Contrast-Induced Nephropathy.长期死亡率与对比剂诱导的肾病

Angiology. 2019 Sep;70(8):783. doi: 10.1177/0003319718823628. Epub 2019 Jan 7.

3

Hemodynamic Stability and Contrast Nephropathy Development in Patients With Acute Myocardial Infarction.急性心肌梗死患者的血流动力学稳定性与造影剂肾病的发生

Angiology. 2020 Mar;71(3):289. doi: 10.1177/0003319719873805. Epub 2019 Sep 10.

4

Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.年龄、肾小球滤过率、射血分数和AGEF评分可预测接受直接经皮冠状动脉介入治疗的急性心肌梗死患者的造影剂肾病。

Catheter Cardiovasc Interv. 2013 Nov 15;82(6):878-85. doi: 10.1002/ccd.25023. Epub 2013 Jun 27.

5

Canada Acute Coronary Syndrome Score: A Preprocedural Risk Score for Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention.加拿大急性冠状动脉综合征评分：直接经皮冠状动脉介入治疗后对比剂肾病的术前风险评分。

Angiology. 2017 Oct;68(9):782-789. doi: 10.1177/0003319717690674. Epub 2017 Jan 31.

6

Is coronary artery disease complexity valuable in the prediction of contrast induced nephropathy besides Mehran risk score, in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention?在接受直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者中，除 Mehran 风险评分外，冠状动脉疾病复杂性对造影剂诱导肾病的预测是否有价值？

Heart Lung Circ. 2013 Oct;22(10):836-43. doi: 10.1016/j.hlc.2013.03.085. Epub 2013 Apr 28.

7

Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention without acute left ventricular ejection fraction impairment.对比剂肾病在接受直接经皮冠状动脉介入治疗而无急性左心室射血分数受损的患者中的发生情况。

Am J Cardiol. 2013 Mar 1;111(5):684-8. doi: 10.1016/j.amjcard.2012.11.018. Epub 2012 Dec 19.

8

Contrast-induced nephropathy in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention.ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后对比剂肾病。

Angiology. 2014 Jan;65(1):37-42. doi: 10.1177/0003319712463816. Epub 2012 Oct 29.

9

Predictive Value of Gamma-Glutamyl Transferase Levels for Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention.接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者中γ-谷氨酰转移酶水平对造影剂诱导的肾病的预测价值

Am J Cardiol. 2015 Sep 1;116(5):711-6. doi: 10.1016/j.amjcard.2015.05.042. Epub 2015 Jun 4.

10

Platelet to Lymphocyte Ratio Predicts Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.血小板与淋巴细胞比值可预测接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者的造影剂诱导的肾病。

Angiology. 2018 Jan;69(1):71-78. doi: 10.1177/0003319717707410. Epub 2017 May 2.

引用本文的文献

1

The relationship between perioperative serum albumin and contrast-induced acute kidney injury in patients after percutaneous coronary intervention.经皮冠状动脉介入治疗后患者围手术期血清白蛋白与对比剂诱导急性肾损伤的关系。

BMC Nephrol. 2024 May 21;25(1):173. doi: 10.1186/s12882-024-03608-9.

2

Risk factors of contrast-induced nephropathy after percutaneous coronary intervention: a retrospective analysis.经皮冠状动脉介入治疗后对比剂肾病的危险因素：一项回顾性分析

J Int Med Res. 2021 Apr;49(4):3000605211005972. doi: 10.1177/03000605211005972.